Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients
Wei‐Shiung Yang(National Taiwan University), Lee‐Ming Chuang(National Taiwan University), Sachiyo Tanaka(Nippon Veterinary and Life Science University), Chi-Yuan Jeng(Tri-Service General Hospital), Chi‐Ling Chen(National Taiwan University), Ta-Jen Wu(National Cheng Kung University Hospital), Yūji Matsuzawa(Sumitomo Hospital), Tong‐Yuan Tai, Tohru Funahashi(The University of Osaka), Jao-Ping Wang(National Taiwan University Hospital)
Cited by 408
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
|The Journal of Clinical Endocrinology & Metabolism|2001|1.2k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
|Journal of the American Society of Nephrology|2002|764